Thoratec Company Profile (NASDAQ:THOR)

About Thoratec (NASDAQ:THOR)

Thoratec logoThoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company's products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company's product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:THOR
  • CUSIP: 88517530
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $63.03
  • 200 Day Moving Avg: $51.62
  • 52 Week Range: $25.04 - $63.51
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 39.44
  • P/E Growth: 0.00
Misc:
  • Average Volume: 1.51 million shs.
 

Frequently Asked Questions for Thoratec (NASDAQ:THOR)

What is Thoratec's stock symbol?

Thoratec trades on the NASDAQ under the ticker symbol "THOR."

How were Thoratec's earnings last quarter?

Thoratec Co. (NASDAQ:THOR) released its earnings results on Tuesday, August, 4th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. The firm earned $128.70 million during the quarter, compared to analysts' expectations of $115.48 million. The business's revenue was up 9.0% on a year-over-year basis. During the same period last year, the business earned $0.43 earnings per share. View Thoratec's Earnings History.

Who are some of Thoratec's key competitors?

How do I buy Thoratec stock?

Shares of Thoratec can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Thoratec stock cost?

One share of Thoratec stock can currently be purchased for approximately $63.50.

Analyst Ratings

Consensus Ratings for Thoratec (NASDAQ:THOR) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Thoratec (NASDAQ:THOR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/3/2015JPMorgan Chase & Co.Reiterated RatingNeutral$36.00 -> $43.00N/AView Rating Details
11/2/2015Leerink SwannBoost Price TargetOutperform$32.00 -> $45.00N/AView Rating Details
11/2/2015Canaccord GenuityBoost Price TargetBuy$39.00 -> $41.00N/AView Rating Details
10/14/2015Goldman Sachs Group IncUpgradeHoldN/AView Rating Details
9/29/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$56.00 -> $60.00N/AView Rating Details
9/25/2015BTIG ResearchReiterated RatingNeutralN/AView Rating Details
8/24/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
7/23/2015Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
7/22/2015Northland SecuritiesDowngradeOutperform -> Market Perform$55.00 -> $63.50N/AView Rating Details
7/15/2015Oppenheimer Holdings Inc.Boost Price TargetOutperform$49.00 -> $52.00N/AView Rating Details
(Data available from 5/23/2015 forward)

Earnings

Earnings History for Thoratec (NASDAQ:THOR)
Earnings by Quarter for Thoratec (NASDAQ:THOR)
Earnings History by Quarter for Thoratec (NASDAQ:THOR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2015Q215$0.28$0.37$115.48 million$128.70 millionViewListenView Earnings Details
5/7/2015Q115$0.26$0.38$111.10 million$121.31 millionViewListenView Earnings Details
2/10/2015Q414$0.24$0.39$106.90 million$127.96 millionViewListenView Earnings Details
11/5/2014Q314$0.22$0.18$106.30 million$105.80 millionViewListenView Earnings Details
8/6/2014Q214$0.43$0.43$128.30 million$118.10 millionViewListenView Earnings Details
5/6/2014Q114$0.39$0.41$122.56 million$125.70 millionViewListenView Earnings Details
2/4/2014Q413$0.41$0.38$128.47 million$128.20 millionViewListenView Earnings Details
10/30/2013Q313$0.40$0.49$121.25 million$126.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.43$0.52$121.51 million$130.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.46$0.41$122.53 million$117.73 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.38$0.38$119.09 million$128.50 millionViewListenView Earnings Details
11/1/2012Q312$0.39$0.41$111.80 million$117.80 millionViewN/AView Earnings Details
8/1/2012$0.45$0.45ViewN/AView Earnings Details
5/1/2012$0.41$0.61ViewN/AView Earnings Details
11/1/2011$0.33$0.41ViewN/AView Earnings Details
8/3/2011$0.35$0.44ViewN/AView Earnings Details
5/3/2011$0.33$0.34ViewN/AView Earnings Details
1/27/2011$0.30$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Thoratec (NASDAQ:THOR)
Current Year EPS Consensus Estimate: $1.37 EPS
Next Year EPS Consensus Estimate: $1.61 EPS

Dividends

Dividend History for Thoratec (NASDAQ:THOR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Thoratec (NASDAQ:THOR)
Insider Trades by Quarter for Thoratec (NASDAQ:THOR)
Insider Trades by Quarter for Thoratec (NASDAQ:THOR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2015Neil F DimickDirectorSell8,173$44.98$367,621.54View SEC Filing  
5/15/2015Paul A LavioletteDirectorSell5,668$44.70$253,359.60View SEC Filing  
4/10/2015Neil F DimickDirectorSell4,786$43.00$205,798.00View SEC Filing  
12/4/2014J Daniel ColeDirectorSell5,000$31.83$159,150.00View SEC Filing  
5/27/2014Neil F DimickDirectorSell4,158$32.15$133,679.70View SEC Filing  
5/15/2014Paul LavioletteDirectorSell6,023$31.23$188,098.29View SEC Filing  
3/10/2014Gerhard BurbachCEOSell22,104$36.53$807,459.12View SEC Filing  
2/11/2014Gerhard BurbachCEOSell20,000$34.71$694,200.00View SEC Filing  
1/15/2014Gerhard BurbachCEOSell9,400$38.10$358,140.00View SEC Filing  
1/14/2014Gerhard BurbachCEOSell30,600$36.65$1,121,490.00View SEC Filing  
12/10/2013Gerhard BurbachCEOSell40,000$38.15$1,526,000.00View SEC Filing  
11/12/2013Gerhard BurbachCEOSell100,000$41.40$4,140,000.00View SEC Filing  
10/28/2013Gerhard F BurbachCEOSell15,000$40.02$600,300.00View SEC Filing  
10/17/2013Gerhard F BurbachCEOSell9,600$39.00$374,400.00View SEC Filing  
10/14/2013Gerhard BurbachCEOSell40,400$38.17$1,542,068.00View SEC Filing  
10/11/2013David Aaron LehmanSVPSell21,889$38.17$835,503.13View SEC Filing  
5/28/2013Neil F DimickDirectorSell1,273$31.58$40,201.34View SEC Filing  
5/20/2013Neil F DimickDirectorSell1,250$31.61$39,512.50View SEC Filing  
5/13/2013Neil F DimickDirectorSell1,250$33.93$42,412.50View SEC Filing  
11/26/2012Gerhard F BurbachCEOSell11,600$38.09$441,844.00View SEC Filing  
10/4/2012David Aaron LehmanSVPSell12,300$36.11$444,153.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Thoratec (NASDAQ:THOR)
Latest Headlines for Thoratec (NASDAQ:THOR)
Source:

Social

Chart

Thoratec (THOR) Chart for Tuesday, May, 23, 2017

This page was last updated on 5/23/2017 by MarketBeat.com Staff